[Danazol: a new hormonal post-coital contraceptive method].

In: Contraception, fertilite, sexualite · 1986 · vol. 14(2) , pp. 131–5 · PMID:12267799 · W136264798
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed
AI-generated summary by gemini-2.5-flash-lite, 2026-07-09

This study compared ethinyl estradiol/norgestrel with danazol for post-coital contraception and found danazol had fewer side effects, reduced nausea and vomiting, and potentially greater efficacy and acceptability.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

During a 9-month period, 84 female patients received post-coital contraception consisting either of an association of ethinyl estradiol/norgestrel or of danazol, in order to compare the safety and any adverse reaction of these 2 treatments. Overall, the patients treated with danazol presented 1/3 as many side effects. Nausea was reduced to 1/3 in frequency and vomiting to 1/9 in this group. 5 pregnancies were confirmed in the ethinyl estradiol/norgesterol group and 2 in the danazol group. Although more cases are needed, it would appear that danazol is characterized by greater efficacy and patient acceptability.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-10T10:18:44.795447+00:00
License: CC0 · commercial use OK